Non-ischemic Cardiomyopathy Clinical Trials

10 recruiting

Non-ischemic Cardiomyopathy Trials at a Glance

10 actively recruiting trials for non-ischemic cardiomyopathy are listed on ClinicalTrialsFinder across 6 cities in 9 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Beijing, Beijing, and Belgrade. Lead sponsors running non-ischemic cardiomyopathy studies include Chinese Academy of Medical Sciences, Fuwai Hospital, Montefiore Medical Center, and Berlin Heals GmbH.

Browse non-ischemic cardiomyopathy trials by phase

Treatments under study

About Non-ischemic Cardiomyopathy Clinical Trials

Looking for clinical trials for Non-ischemic Cardiomyopathy? There are currently 10 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Non-ischemic Cardiomyopathy trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Non-ischemic Cardiomyopathy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting
Not Applicable

Performance of the Cardiac Microcurrent (C-MIC) System With a Less Invasively Placed Left Ventricular Lead

Non-ischemic CardiomyopathyLeft Ventricular (LV) Systolic DysfunctionIdiopathic Cardiomyopathy
Berlin Heals GmbH22 enrolled4 locationsNCT06920030
Recruiting

Cardiac Magnetic Resonance for Risk Stratification in Non-dilated Left Ventricular Cardiomyopathy

Non-ischemic Cardiomyopathy
Chinese Academy of Medical Sciences, Fuwai Hospital1,000 enrolled1 locationNCT07351838
Recruiting
Not Applicable

Cardiac RadiothErapy For hEart faiLure

Heart FailureNon-ischemic CardiomyopathyIschemic Cardiomyopathy
Universitaire Ziekenhuizen KU Leuven40 enrolled1 locationNCT06661876
Recruiting

Non-ischemic Cardiomyopathy Registry, Biobank and Imaging Data Repository

Non-ischemic Cardiomyopathy
Montreal Heart Institute2,000 enrolled1 locationNCT07110818
Recruiting

Development of CIRC Technologies

Heart FailureCardiovascular DiseasesAtrial Fibrillation+7 more
The Cleveland Clinic1,000 enrolled1 locationNCT05654272
Recruiting
Not Applicable

LBBP as Initial Therapy in Patients With Non-ischemic Heart Failure and LBBB

Heart FailureNon-ischemic CardiomyopathyLeft Bundle-Branch Block
The First Affiliated Hospital with Nanjing Medical University50 enrolled6 locationsNCT05572957
Recruiting

Cardiovascular Multimodality Imaging Study

CardiomyopathiesSarcoidosisHypertrophic Cardiomyopathy+4 more
Montefiore Medical Center5,000 enrolled1 locationNCT06610019
Recruiting

Multimodal and Multidisciplinary Approach to Optimize Diagnostic, Prognostic, and Therapeutic Management of Patients with Non-ischemic Cardiomyopathies and Arrhythmogenic-inflammatory Phenotypes: a Multicenter, Observational, Retrospective and Prospective Registry Study.

Hypertrophic Cardiomyopathy (HCM)Non-ischemic CardiomyopathyRestrictive Cardiomyopathy+2 more
Scientific Institute San Raffaele15,000 enrolled1 locationNCT06607471
Recruiting

Relationship Between Coronary Microvascular Dysfunction and Improvement of Left Ventricular Systolic Function in Patients With Heart Failure With Reduced Ejection Fraction Caused by Non-ischemic Etiology

Heart FailureNon-ischemic CardiomyopathyMicrovascular Angina
Samsung Medical Center200 enrolled1 locationNCT06243653
Recruiting

DZHK TORCH-Plus is a Registry for Patients With Cardiomyopathies and Serves as Source for Cardiovascular Research Studies

AmyloidosisNon-ischemic CardiomyopathyArrhythmogenic Right Ventricular Cardiomyopathy+5 more
University Hospital Heidelberg2,040 enrolled1 locationNCT04265040